Literature DB >> 4054714

Occult, high-risk endometrial cancer.

M Smith, A J McCartney.   

Abstract

In a series of 173 consecutive patients with endometrial cancer treated by a fixed protocol 62 tumors (36%) appear "estrogen independent," i.e. there is no history of estrogen ingestion and no recognized risk factors such as obesity or diabetes mellitus. A high proportion of these tumors are of advanced stage and grade. Prognosis is poorer and mortality higher than for "estrogen-dependent" tumors. Twenty-two tumors were truly occult (no spontaneous vaginal bleeding). Factors which identify this high-risk group are described and the reasons for delay in diagnosis discussed. Spread by intraperitoneal dissemination is considered a major factor in the poorer prognosis. Cytology of peritoneal washings is a useful diagnostic and prognostic aid. An estrogen provocation test is suggested as a means of earlier recognition which could reduce mortality in this group.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054714     DOI: 10.1016/0090-8258(85)90021-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Poorer prognosis in older patients with endometrial adenocarcinoma.

Authors:  E Hernandez; D DeFilippis; K O'Connell; G Balsara; S Keyamanesh; L Anderson; P B Heller
Journal:  J Natl Med Assoc       Date:  1996-02       Impact factor: 1.798

2.  Involvement of chromosome 6 in endometrial cancer.

Authors:  M G Tibiletti; B Bernasconi; M Taborelli; D Furlan; A Fabbri; M Franchi; R Taramelli; M Trubia; C Capella
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Hormone replacement therapy and risk of epithelial ovarian cancer.

Authors:  D M Purdie; C J Bain; V Siskind; P Russell; N F Hacker; B G Ward; M A Quinn; A C Green
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.